{"id":"https://openalex.org/W2805705672","doi":"https://doi.org/10.29271/jcpsp.2018.06.s89","title":"Lenalidomide Induced Toxic Epidermal Necrolysis And Del (5q): Co-occurrence Of Rarities","display_name":"Lenalidomide Induced Toxic Epidermal Necrolysis And Del (5q): Co-occurrence Of Rarities","publication_year":2018,"publication_date":"2018-06-01","ids":{"openalex":"https://openalex.org/W2805705672","doi":"https://doi.org/10.29271/jcpsp.2018.06.s89","mag":"2805705672","pmid":"https://pubmed.ncbi.nlm.nih.gov/29866231"},"language":"en","primary_location":{"id":"doi:10.29271/jcpsp.2018.06.s89","doi":"https://doi.org/10.29271/jcpsp.2018.06.s89","is_oa":false,"landing_page_url":"https://doi.org/10.29271/jcpsp.2018.06.s89","pdf_url":null,"source":{"id":"https://openalex.org/S4210202897","display_name":"Journal of College of Physicians And Surgeons Pakistan","issn_l":"1022-386X","issn":["1022-386X","1681-7168"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4322697874","host_organization_name":"College of Physicians and Surgeons Pakistan","host_organization_lineage":["https://openalex.org/P4322697874"],"host_organization_lineage_names":["College of Physicians and Surgeons Pakistan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the College of Physicians and Surgeons Pakistan","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015537039","display_name":"Qamar Un Nisa Chaudhry","orcid":"https://orcid.org/0000-0002-3929-2480","observed_orcids":["https://orcid.org/0000-0002-3929-2480"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qamar un Nisa Chaudhry","raw_affiliation_strings":["Department of Hematology, Armed Forces Bone Marrow Transplant Centre, Rawalpindi"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Armed Forces Bone Marrow Transplant Centre, Rawalpindi","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084631381","display_name":"Raheel Iftikhar","orcid":"https://orcid.org/0000-0001-8767-3491","observed_orcids":["https://orcid.org/0000-0001-8767-3491"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Raheel Iftikhar","raw_affiliation_strings":["Department of Medicine, Armed Forces Bone Marrow Transplant Centre, Rawalpindi"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Armed Forces Bone Marrow Transplant Centre, Rawalpindi","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108491975","display_name":"Tariq Mahmood Satti","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tariq Mehmood Satti","raw_affiliation_strings":["Department of Hematology, Armed Forces Bone Marrow Transplant Centre, Rawalpindi"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Armed Forces Bone Marrow Transplant Centre, Rawalpindi","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033849244","display_name":"Syed Kamran Mahmood","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Syed Kamran Mahmood","raw_affiliation_strings":["Department of Medicine, Armed Forces Bone Marrow Transplant Centre, Rawalpindi"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Armed Forces Bone Marrow Transplant Centre, Rawalpindi","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016607253","display_name":"Mehreen Ali Khan","orcid":"https://orcid.org/0000-0002-0233-0498","observed_orcids":["https://orcid.org/0000-0002-0233-0498"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mehreen Ali Khan","raw_affiliation_strings":["Department of Hematology, Armed Forces Bone Marrow Transplant Centre, Rawalpindi"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Armed Forces Bone Marrow Transplant Centre, Rawalpindi","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079999903","display_name":"Nighat Shahbaz","orcid":"https://orcid.org/0000-0003-4206-7038","observed_orcids":["https://orcid.org/0000-0003-4206-7038"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nighat Shahbaz","raw_affiliation_strings":["Department of Hematology, Armed Forces Bone Marrow Transplant Centre, Rawalpindi"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Armed Forces Bone Marrow Transplant Centre, Rawalpindi","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1823,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.4979935,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"28","issue":"6","first_page":"S89","last_page":"S90"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":0.76419997215271,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":0.76419997215271,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.10809999704360962,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.013399999588727951,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":0.968999981880188},{"id":"https://openalex.org/keywords/toxic-epidermal-necrolysis","display_name":"toxic epidermal necrolysis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/del-5q","display_name":"del(5q)","score":0.824999988079071},{"id":"https://openalex.org/keywords/primary-myelofibrosis","display_name":"primary myelofibrosis","score":0.9660000205039978},{"id":"https://openalex.org/keywords/calr-mutation","display_name":"CALR mutation","score":0.906000018119812},{"id":"https://openalex.org/keywords/drug-induced-skin-toxicity","display_name":"drug-induced skin toxicity","score":0.7120000123977661},{"id":"https://openalex.org/keywords/myeloproliferative-neoplasms","display_name":"myeloproliferative neoplasms","score":0.9240000247955322},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.7559999823570251}],"concepts":[{"id":"https://openalex.org/C2780664588","wikidata":"https://www.wikidata.org/wiki/Q1878682","display_name":"Toxic epidermal necrolysis","level":2,"score":0.8340409994125366},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.7488893270492554},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4157015085220337},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.2789871096611023},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1616407036781311},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.04855066537857056}],"mesh":[{"descriptor_ui":"D000077269","descriptor_name":"Lenalidomide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000077269","descriptor_name":"Lenalidomide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000748","descriptor_name":"Anemia, Macrocytic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D002872","descriptor_name":"Chromosome Deletion","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D002895","descriptor_name":"Chromosomes, Human, Pair 5","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003582","descriptor_name":"Cytogenetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007155","descriptor_name":"Immunologic Factors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007155","descriptor_name":"Immunologic Factors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013262","descriptor_name":"Stevens-Johnson Syndrome","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D037282","descriptor_name":"Calreticulin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D055728","descriptor_name":"Primary Myelofibrosis","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D055728","descriptor_name":"Primary Myelofibrosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.29271/jcpsp.2018.06.s89","doi":"https://doi.org/10.29271/jcpsp.2018.06.s89","is_oa":false,"landing_page_url":"https://doi.org/10.29271/jcpsp.2018.06.s89","pdf_url":null,"source":{"id":"https://openalex.org/S4210202897","display_name":"Journal of College of Physicians And Surgeons Pakistan","issn_l":"1022-386X","issn":["1022-386X","1681-7168"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4322697874","host_organization_name":"College of Physicians and Surgeons Pakistan","host_organization_lineage":["https://openalex.org/P4322697874"],"host_organization_lineage_names":["College of Physicians and Surgeons Pakistan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the College of Physicians and Surgeons Pakistan","raw_type":"journal-article"},{"id":"pmid:29866231","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29866231","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the College of Physicians and Surgeons--Pakistan : JCPSP","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1985619207","https://openalex.org/W7172306690","https://openalex.org/W2007515486","https://openalex.org/W2084267209","https://openalex.org/W2592413587","https://openalex.org/W4392915127","https://openalex.org/W2151275211","https://openalex.org/W2340404241","https://openalex.org/W2531895827","https://openalex.org/W2131128792"],"abstract_inverted_index":{"Primary":[0],"myelofibrosis":[1],"(PMF)":[2],"is":[3,39,48,126],"a":[4,75,114],"clonal,":[5],"BCR-ABL1":[6],"negative":[7],"myeloproliferative":[8],"neoplasm":[9],"characterised":[10],"by":[11],"splenomegaly,":[12],"leukoerythroblastic":[13],"peripheral":[14],"blood":[15],"picture":[16],"and":[17,34,47,53,84],"bone":[18],"marrow":[19],"fibrosis.":[20],"Different":[21],"cytogentic":[22],"abnormalities":[23],"are":[24,71,113],"documented":[25,40],"in":[26,41,117,137],"PMF":[27,45],"which":[28],"have":[29],"impact":[30],"on":[31,100],"clinical":[32],"outcome":[33,52],"overall":[35],"survival.":[36],"Del":[37],"5q31":[38],"only":[42],"0.8%":[43],"of":[44,56,74,130],"patients":[46,118,138],"associated":[49],"with":[50,62,80,119,139],"poor":[51],"increased":[54],"risk":[55],"progression":[57],"to":[58,67,123],"acute":[59],"leukemia.":[60],"Anemia":[61],"del":[63,94],"5q":[64,95],"responds":[65],"frequently":[66],"lenalidomide":[68,101,108,120,131],"treatment.":[69],"We":[70],"reporting":[72],"case":[73,129],"middle-aged":[76],"male":[77],"who":[78],"presented":[79],"constitutional":[81],"symptoms,":[82],"myelofibrosis;":[83],"calreticulin":[85],"type":[86],"2":[87],"mutation":[88],"was":[89,98,109],"present.":[90],"His":[91],"cytogenetics":[92],"showed":[93],"positivity.":[96],"He":[97],"started":[99],"but":[102,122],"developed":[103],"toxic":[104,133],"epidermal":[105,134],"necrolysis,":[106],"resultantly":[107],"stopped.":[110],"Skin":[111],"eruptions":[112],"known":[115],"entity":[116],"therapy;":[121],"date,":[124],"there":[125],"no":[127],"reported":[128],"induced":[132],"necrolysis":[135],"(TEN)":[136],"myelofibrosis.":[140]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2018-06-13T00:00:00"}